Answer
Patients receiving denosumab may develop skin infections, predominantly cellulitis, leading to hospitalisation, and should seek prompt medical attention for signs or symptoms of cellulitis.
Sources for this answer
- Prolia 60 mg solution for injection in pre-filled syringeAmgen Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 38Document updated
Sources checked